1. (a) Diseases of the pituitary, thyroid, parathyroid, thymus, and adrenal glands.
2. (b) Growth hormone deficiency.
3. (c) Diseases of the ovaries or testicles in which there is delayed onset of puberty primary amenorrhea after the age of 15 years, sexual development prior to the age of eight years for females and nine years for males, feminization of a male, or virilization of a female.
4. (d) Diseases of the pancreas resulting in pancreatic dysfunction.
5. (e) Diabetes mellitus.
6. (f) Diseases due to congenital or acquired immunologic deficiency manifested by life-threatening infections, as determined from medical information about the applicant's clinical course and laboratory studies.
7. (g) Inborn errors of metabolism such as phenylketonuria, homocystinuria, galactosemia, glycogen storage disease and maple syrup urine disease.
8. (h) Cystic fibrosis.

CCS applicants with at least one of the following conditions shall be medically eligible for participation in the CCS program:

Note: Authority cited: Sections 20 and 100275, Health and Safety Code. Reference: Sections 123830 and 123835, Health and Safety Code.

History

1. New section filed 1-7-92 as an emergency; operative 1-7-92 (Register 92, No. 13). A Certificate of Compliance must be transmitted to OAL 5-5-92 or emergency language will be repealed by operation of law on the following day.

2. Certificate of Compliance as to 1-7-92 order including amendment of section transmitted to OAL 5-6-92 and filed 6-17-92 (Register 92, No. 25).

3. Change without regulatory effect renumbering former section 41516.1 to new section 41431 and renumbering former section 41819 to section 41516.1, including amendment of Note, filed 1-28-2009 pursuant to section 100, title 1, California Code of Regulations (Register 2009, No. 5).